EndoTheranostics

EndoTheranostics is at the forefront of pioneering research services, dedicated to revolutionizing the theranostics of Colorectal Cancer (CRC). With a strong commitment to enhancing the quality of life for millions, EndoTheranostics is focused on impactful advancements in healthcare.

EndoTheranostics operates as an ERC Synergy project, driving innovation through cutting-edge research and development. The company is committed to creating groundbreaking solutions that address critical challenges in theranostics. The dedicated team at EndoTheranostics works diligently to push the boundaries of medical science and deliver meaningful results.

Funded by the European Union under Grant Agreement 101118626, EndoTheranostics continues to expand its research capabilities and broaden its impact on global healthcare. We invite the management team at EndoTheranostics to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and success.